KalGene Pharmaceuticals

About:

KalGene Pharmaceuticals is a biotech company that develops precision medicine therapeutics for patients suffering from Alzheimer's disease.

Website: http://www.kalgene.com

Top Investors: Lumira Ventures, AQC Capital, Ontario Brain Institute, CQDM, Anges Quebec

Description:

KalGene Pharmaceuticals, Inc. is a privately held company working in partnership with many of North America and Europe’s leading clinician-scientists and academic institutions. KalGene is focused on the development of targeted therapeutics and companion diagnostics. Its programs are aimed at improving clinical and survival outcomes through the use of personalized medicine. Personalized medicine seeks to predict which patients will respond to a particular therapy in advance of treatment. This prediction allows physicians to prescribe treatment according to an individual’s specific biological signature, or needs.

Total Funding Amount:

$7.56M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Montréal, Quebec, Canada

Founded Date:

2007-01-01

Contact Email:

info(AT)kalgene.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2021-06-22

IPO Status:

Private

Industries:

© 2025 bioDAO.ai